Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CraniUS
AddedFeb 15, 2024
UpdatedJun 18, 2026
CraniUS

CraniUS

Series A

CraniUS: Innovating world-class medical equipment for advanced neurosurgical diagnostics and treatments.

HQ
Cockeysville, MD, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

CraniUS, founded with the mission to revolutionize neurosurgical diagnostics and treatments, focuses on developing advanced medical equipment for brain disease patients. The company's vision is to create world-class technology that defines the future of brain health. CraniUS offers a groundbreaking product: the first smart, refillable, and fully implantable device for direct medicine delivery to the brain, featuring a novel wireless charging system. This innovation targets the neurosurgical market, aiming to improve patient outcomes through precise and chronic drug delivery.

CraniUS has attracted notable investors and industry experts passionate about transforming brain disease treatment. The company's key achievements include the development and successful testing of its flagship device, which promises to set new standards in neurosurgical care. By focusing on direct and customizable drug delivery, CraniUS has made a significant impact on the medical field, offering hope for improved management of chronic brain conditions.

CraniUS - Similar Companies

CranioVation logo

CranioVation

craniovation.com

BrainSpace logo

BrainSpace

brainspacemed.com

Longeviti logo

Longeviti

longeviti.com

BrainHealth logo

BrainHealth

Neurosonics Medical logo

Neurosonics Medical

CranioSense logo

CranioSense

craniosense.com

Deep Brain Innovations logo

Deep Brain Innovations

CereVasc logo

CereVasc

cerevasc.com

Precision Neuroscopics logo

Precision Neuroscopics

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

Cremedical logo

Cremedical

cremedical.com

Boston Neurosciences logo

Boston Neurosciences

NeuroBionics logo

NeuroBionics

ClearPoint Neuro logo

ClearPoint Neuro

Jan Medical logo

Jan Medical

janmedical.com

CraniUS - Quick Facts

Who are CraniUS' competitors?

Companies similar to CraniUS include CranioVation, BrainSpace, Longeviti and BrainHealth.

When was CraniUS founded?

CraniUS was founded in 2021.

Where is CraniUS' headquarters located?

CraniUS' headquarters is located in Cockeysville, MD, US.

When was CraniUS' last funding round?

CraniUS' most recent funding round was for $19.4M (USD) in September 2022.

How much has CraniUS raised to-date?

As of Sep 27, 2022, CraniUS has raised a total of $19.9M (USD).

How many employees does CraniUS have?

CraniUS has 27 employees as of Feb 4, 2024.

CraniUS - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified